Onconova Therapeutics, Inc. (NASDAQ:ONTX)
Onconova Therapeutics, Inc. (NASDAQ:ONTX) represented a move of 0 percent or $0.15 per share and closed its previous day trading session at $3.93. 0 Shares were traded in the last trading session with an Average Volume of 150.82 Million Shares. The stock currently has a Market Capitalization of 22.3 Million.
Onconova Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecule drug candidates to treat cancer. The Company’s products under different phases of development include Rigosertib intravenous (IV), Rigosertib Oral, Rigosertib IV, ON 013105 and Recilisib. Onconova Therapeutics, Inc. is headquartered in Newtown, Pennsylvania.
The stock traded between $ 3.27 and $39.97 over 1-Year time period showing its price to sales ratio of 17.15. Onconova Therapeutics, Inc. (NASDAQ:ONTX) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-27.25 and 200-Day Simple Moving Average of $-50.54. Its Price to Free Cash Flow is 0 and Price to Book of 2.06.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Onconova Therapeutics, Inc. (NASDAQ:ONTX) reported its Actual EPS of $-0.94/share. The analysts offering Earnings Estimates for the company were believing that Onconova Therapeutics, Inc. could bring EPS of $-1.16/share. The difference between Actual EPS and Estimated EPS was 0.22 Percent. Thus showing an Earnings Surprise of 19 Percent.
CAS Medical Systems, Inc. (NASDAQ:CASM)
In the last trading session, CAS Medical Systems, Inc. (NASDAQ:CASM) added its value by 0% closing at the price of $1.92. The stock currently has market capitalization of 56.29 Million, with average volume of 55.2 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently CAS Medical Systems, Inc. (NASDAQ:CASM) is showing beta of -0.1. This particular value of beta suggests that CAS Medical Systems, Inc. (NASDAQ:CASM) has historically moved -10% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for CAS Medical Systems, Inc. (NASDAQ:CASM) is at $-0.06.
The stock currently has RSI of 49.61. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
CAS Medical Systems, Inc. develops and manufactures high-quality blood pressure measurement devices, vital signs monitors, apnea monitors and neonatal supplies that are the first choice of health care professionals around the world. CAS has earned a reputation for providing innovative, reliable products and backing them up with expert technical support. It works closely with health care providers to significantly improve the quality of patient care.
CAS Medical Systems, Inc. (NASDAQ:CASM) topped its 52-week high price of $2.70 on 08/10/18 and 52-Week Low Price of $0.59 on 12/06/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 7.54% and monthly volatility of 6.02% respectively.